FDA finalizes clinical guidance for psychedelic drugs, easing abuse-study requirements, and sets a Sept. 14 hearing on therapeutic use.

FDA finalizes clinical guidance for psychedelic drugs, easing abuse-study requirements, and sets a Sept. 14 hearing on therapeutic use.

News and commentary from the psychiatry world